Vibeke Strand
Rheumatology · Portola Valley, CANPI 1194882753
Payments from drug & device makers
Across 444 payments — averaging $1737.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$204K
- Amgen$80K
- E.r. Squibb & Sons, L.L.C.$60K
- Boehringer Ingelheim$58K
- Novartis$51K
- Astrazeneca UK Limited$48K
- plus $270K from 31 others
Across 64 payments — averaging $1100.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$19K
- Pfizer$13K
- Novartis$9K
- Bioventus LLC$9K
- Endo Pharmaceuticals Inc.$8K
- Amgen$6K
- plus $7K from 3 others
What the payments were for
- Consulting fees$545,27078%
- Speaking & faculty fees$112,57816%
- Grants$7,7631%
- Travel & lodging$27,9734%
- Food & beverage$6,9411%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 98 | $203,789 |
| Amgen(2 entities) | 58 | $80,096 |
| E.r. Squibb & Sons, L.L.C. | 56 | $60,473 |
| Boehringer Ingelheim | 20 | $57,738 |
| Novartis | 32 | $51,182 |
| Astrazeneca UK Limited | 19 | $47,563 |
| Pfizer | 18 | $37,873 |
| AstraZeneca | 14 | $22,353 |
| Whitehall International Inc | 4 | $21,743 |
| Bioventus LLC | 8 | $21,613 |
| Pacira Therapeutics, Inc. | 8 | $19,079 |
| Novartis Pharma AG | 4 | $18,053 |
| EMD Serono, Inc. | 5 | $17,639 |
| Gilead | 4 | $14,273 |
| Bayer | 18 | $13,397 |
| Swedish Orphan Biovitrum AB | 4 | $13,308 |
| Sanofi-aventis U.S. LLC | 11 | $11,577 |
| Regeneron Healthcare Solutions, Inc. | 15 | $10,345 |
| Sanofi US Services Inc. | 2 | $8,910 |
| Eli Lilly | 5 | $6,414 |
| GSK | 3 | $5,411 |
| Pacira Pharmaceuticals Incorporated | 1 | $5,040 |
| Sandoz | 3 | $4,886 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $4,763 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $3,300 |
| Shionogi Inc | 1 | $2,800 |
| Samsung Bioepis Co., Ltd. | 3 | $2,610 |
| Sobi, Inc | 5 | $2,279 |
| Sanofi | 3 | $1,728 |
| Lilly USA, LLC | 5 | $284 |
| UCB, Inc. | 3 | $191 |
| Janssen Scientific Affairs, LLC | 3 | $158 |
| Aurinia Pharma U.S., Inc. | 1 | $117 |
| Bristol Myers Squibb | 2 | $109 |
| Regeneron | 2 | $96 |
| Genentech, Inc. | 1 | $31 |
| Genentech USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COSENTYX$48,866
- SAPHNELO$45,013
- XELJANZ$41,695
- KRYSTEXXA$34,812
- KEVZARA$32,361
- Skyrizi$27,288
- Tavneos$23,209
- Zilretta$19,075
- Sprifermin$17,375
- Essure$13,184
- INFLECTRA$12,513
- Rinvoq$10,478
- CEC_COSENTYX_IMMUNOLOGY$9,735
- Enbrel$6,026
- Sotyktu$5,999
- ERELZI$4,886
- COSENTYX_COSENTYX_DERMATOLOGY$4,543
- Humira$4,500
- DIOVAN$1,019
- SB35$700
How this compares
$771,235 in reported general payments places this provider in the 90th percentile of 808 rheumatology providers in California.
Other rheumatology in Portola Valley
- Samy MetyasCovina$12.9M
- Christine ThaiHuntington Beach$8.5M
- Tien-I SuWhittier$8.4M
- Eric LeeUpland$6.9M
- Orrin TroumSanta Monica$6.9M
- Shirley PangFullerton$5.7M
- William RobinsonStanford$5.1M
- Dan laTujunga$5.1M
- Christina Charles-SchoemanLos Angeles$4.8M
- Suneet GrewalWest Hollywood$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.